This page contains recent news articles, when available, and an overview of but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Background information on

Business Intelligence Applications for Specialty Healthcare ...  -  25 Mar 2008
B-EYE-Network,Letâ€™s take a look at an example â€“ nephropathy or kidney care. Kidney care involves a large number of products, services and activities delivered through

Keryx says diabetic nephropathy drug misses primary endpoint in ...  -  Mar 10, 2008
CNNMoney.comThe drug was designed to treat diabetic nephropathy. The company said the results for patients tested were similar to the results for patients on a placebo.

Keryx Biopharma's Phase 3 Trial Of Sulonex For Diabetic ...  -  Mar 7, 2008
RTT News,3/7/2008 8:22:30 PM Keryx Biopharmaceuticals, Inc. (KERX) announced that Phase 3 clinical trial of Sulonex for the treatment of diabetic nephropathy failed

Keryx's Phase 3 Clinical Trial Of Sulonex For Diabetic Nephropathy ...  -  Mar 7, 2008
Trading Markets (press release),Inc. (KERX | news | PowerRating | PR Charts ) announced that Phase 3 clinical trial of Sulonex for the treatment of diabetic nephropathy failed to meet

Statins reduce contrast-induced nephropathy  -  Mar 5, 2008
Medicexchange,After the procedure, the 260 statin-treated patients had a significantly lower incidence of contrast-induced nephropathy (three per cent) than did the 174

GlaxoSmithKline to Pay Pharmacopeia $5M  -  Mar 18, 2008
CNNMoney.comPharmacopeia is developing small-molecule treatments for high blood pressure, diabetic nephropathy, muscle wasting, inflammation and respiratory disease.

PLC Systems Gets FDA Approval To Begin Pivotal Study Of RenalGuard ...  -  Mar 20, 2008
RTT News,...in a US pivotal trial to study the effectiveness of its RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.

PLC Systems (PLC) Receives FDA Conditional Approval to Commence ...  -  Mar 20, 2008
StreetInsider.com (subscription),Contrast-Induced Nephropathy, or CIN, is a major and growing problem due to the increasing number of older patients, diabetics and patients with pre-

Uric Acid May Provide Early Clues To Diabetic Kidney Disease  -  Mar 20, 2008
Science Daily (press release)None of the patients had higher levels of albumin (albuminuria) representing more advanced diabetic nephropathy. Nevertheless, one in five had some

PLC to Commence Pivotal Study of RenalGuard  -  Mar 21, 2008
OneMedPlace,RenalGuard is an investigational therapy targeting patients with diminished renal function who may be at risk for Contrast-Induced Nephropathy,

PLC to Begin Study of RenalGuard  -  Mar 20, 2008
FDA news (subscription),...received conditional approval from the FDA to begin enrollment in a trial to study RenalGuard for the prevention of contrast-induced nephropathy (CIN).

Diabetes - Resveratrol may help prevent Blood Vessel Damage  -  Mar 18, 2008
Best Syndication,Elevated levels of glucose in the blood are associated with increased risk for retinopathy, nephropathy, and heart disease.

PLC: FDA Approval to Begin Trial of RenalGuard Therapy(TM) and ...  -  Mar 20, 2008
Trading Markets (press release),...to study the effectiveness of the Company's RenalGuard Therapy(TM) and RenalGuard System(TM) in the prevention of Contrast-Induced Nephropathy (CIN).

Uric acid may predict kidney function in diabetics  -  Mar 17, 2008
Food Consumer,The results indicated that uric acid is a better predictor for the risk of nephropathy in patients with type 1 diabetes than urine albumin.

Home dialysis plea to give kidney patients more normal lives  -  Mar 24, 2008
Scotsman,Mr Middleton was diagnosed with the condition IgA nephropathy, which causes progressive kidney damage. To start with, his condition was managed with drugs

12 hospitals to offer volunteer consultations  -  Mar 12, 2008
EastDay.com,The nephropathy department of Shanghai Medical Association will gather 12 hospitals in the city to give volunteer medical consultations on the third World

Inexpensive Drug Found Best for Renoprotection from Contrast Agent  -  Feb 26, 2008
MedPage Today,A 25-cent N-acetylcysteine pill appeared to provide the most consistent protection against nephropathy caused by iodine-based imaging contrast agents,

Sulonex from Keryx: Unlikely Phase III Success  -  Feb 27, 2008
Seeking Alpha,Though its mechanism of action in diabetic nephropathy is uncertain, it is hypothesized that sulodexide â€“ a gylcosaminoglycan [GAG] â€“ restores the anionic

HbA1c ineffective as glycemic control predictor in patients on ...  -  Feb 27, 2008
Endocrine Today,Compared to those without nephropathy, patients with ESRD had higher mean serum glucose concentrations and higher glycemic albumin, but lower HbA1c.

Keryx Biopharma shares dive on failed late-stage study  -  Mar 10, 2008
Therapeutics Daily (subscription) (press release),On March 7, Keryx said a late phase clinical trial for its drug candidate Sulonex, designed to treat diabetic nephropathy, failed to meet the main goal of

Clinical trial fails for Keryx Biopharmaceuticals  -  Mar 10, 2008
SmallCapInvestorDiabetic nephropathy is a progressive kidney disease that results in an increase in blood pressure (hypertension) and fluid retention in the body.

PLC Systems Receives FDA Approval To Commence Pivotal Study Of ...  -  Mar 22, 2008
Medical News Today (press release),Contrast-Induced Nephropathy, or CIN, is a major and growing problem due to the increasing number of older patients, diabetics and patients with pre-

Before a CT scan, many should take drug to protect kidneys  -  Feb 28, 2008
Sun-Sentinel.com,Only N-acetylcysteine clearly prevented contrast-induced nephropathy, the medical name for kidney damage caused by contrast agents.

Types of Chronic Complications-Diabetes  -  Feb 26, 2008
American Chronicle,In a patient with Type 1 diabetes, diabetic nephropathy typically progress through five stages. Stage I Stage I, which occurs soon after the onset of

Keryx Takes Major Hit as Sulonex Fails Phase III.  -  Mar 11, 2008
Therapeutics Daily (subscription) (press release),Keryx BioPharmaceuticals Inc. said its Phase III study of Sulonex for diabetic nephropathy failed to meet its primary endpoint, causing the company's stock

Rituximab May Reduce IMN Proteinuria  -  Feb 27, 2008
Renal and Urology News,RITUXIMAB MAY decrease proteinuria in patients who have idiopathic membranous nephropathy (IMN) and severe nephrotic syndrome, according to investigators.

Grape Skin Compound Fights The Complications Of Diabetes  -  Mar 20, 2008
Science Daily (press release)Complications that can result when this happen include nephropathy (kidney disease), heart disease and retinopathy (which if left untreated can lead to

Conventional management of VUR in children questioned  -  Feb 29, 2008
AAP News (subscription)Presence of renal scarring (reflux nephropathy) in patients with VUR and no UTI, such as those with VUR diagnosed during follow-up for antenatal

Novel Discovery Could Lead To Much-needed Kidney Failure Treatment  -  Mar 15, 2008
Science Daily (press release)Collectively, the observations made in the Einstein study offer strong evidence that aberrant Notch signaling is also involved in diabetic nephropathy (DNP)

Diabetic family man needs financial help  -  Mar 14, 2008
Inquirer.net,Manila, every four months to monitor by ultrasound the condition of his chronic kidney disease (stage three) secondary to diabetes mellitus nephropathy.

Synvista Therapeutics Highlights Newly Published Data ...  -  Mar 5, 2008
PharmaLive.com (press release),Synvista Therapeutics is a biopharmaceutical company developing drugs to treat and prevent cardiovascular disease and nephropathy in people with diabetes.

MicroRNAs and gene regulation in the epithelial-mesenchymal transition  -  Mar 21, 2008
The New York Academy of Sciences,One is aristolochic acid nephropathy, in which patients develop progressive renal cortical tubular atrophy and fibrosis, as well as urothelial tumors,

Pharmacopeia Initiates Second Phase 2 Hypertension Study With  -  Mar 4, 2008
Pharmaceutical Online (press release),...angiotensin (AII) and endothelin (ET1) receptor antagonist that is being developed as a potential treatment for hypertension and diabetic nephropathy.

Insulin Restriction in Women With Type 1 Diabetes May Increase ...  -  Feb 29, 2008
Medscape (subscription)Insulin restriction in women with type 1 diabetes is associated with higher rates of self-reported nephropathy and foot problems.

Renal Decline More Rapid in HIV Patients  -  Feb 26, 2008
Renal and Urology News,Just like with diabetic nephropathy, small amounts of albumin predict the development of big amounts of protein down the road.â€? In diabetic nephropathy

McDonald's, Nationwide Get a Boost  -  Mar 10, 2008
Wall Street Journal...after the company released disappointing data from a trial of Sulonex, its treatment for diabetic nephropathy, a kidney disease caused by diabetes.

Movers: MBIA, Countrywide, Virgin Media, Fannie Mae  -  Mar 10, 2008
BusinessWeekKeryx Biopharmaceuticals (KERX) announces top-line results from its SUN-MICRO Phase 3 clinical trial of Sulonex for treatment of diabetic nephropathy,

Out of the Gate: Keryx Plunges  -  Mar 10, 2008
CNNMoney.comOn Friday, the New York-based company said Sulonex was not more effective than a placebo in treating diabetic nephropathy, or kidney disease brought on by

Keryx Biopharma says SUN-MICRO Phase 3 trial of Sulonex fails to ...  -  Mar 9, 2008
CNNMoney.com...said the SUN-MICRO Phase 3 clinical trial of Sulonex for the treatment of diabetic nephropathy failed to meet the primary endpoint of the study.

DiObex and Camurus Sign License Agreement for the Development of ...  -  Mar 18, 2008
Earthtimes,...single enantiomer of ketoconazole that is a novel cortisol synthesis inhibitor in development for type 2 diabetes mellitus and diabetic nephropathy.

Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline  -  Mar 18, 2008
Earthtimes,Phase 1 development addressing multiple indications including hypertension, diabetic nephropathy, muscle wasting, inflammation and respiratory disease.

BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce ...  -  Mar 17, 2008
Trading Markets (press release),Additional observations from the trial included a statistically significant reduction in cisplatin-induced kidney damage (nephropathy) and a statistically

Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor  -  Mar 17, 2008
Earthtimes,...develops products that treat chronic inflammatory conditions and accelerated aging diseases such as diabetic nephropathy and retinopathy.

BUYINS.NET: JMBA, KERX, STEN, TELK, JYHW, TMLN Have Also Been ...  -  Mar 17, 2008
Trading Markets (press release),The company's endocrine/renal products include Sulonex, a Phase III and Phase IV clinical stage product for the treatment of diabetic nephropathy;

Dumaguing: The slim insulin  -  Mar 16, 2008
Sun.Star,...nephropathy or kidney pathology and retinopathy leading to blindness -- as well as its macrovascular complications -- heart attack and stroke.

New Study may Pave the Way for Kidney Failure Treatment  -  Mar 13, 2008
MedIndia,The researchers' observation during the study offers strong evidence that aberrant Notch signaling plays a role in diabetic nephropathy (DNP) and focal

Breakthrough in treatment of kidney failure  -  Mar 13, 2008
Thaindian.com,...the observations made in the Einstein College study offer strong evidence that aberrant Notch signalling is also involved in diabetic nephropathy (DNP)

HMC plans a slew of events to mark World Kidney Day  -  Mar 11, 2008
Gulf Times,...â€˜Cadaver transplants in Qatarâ€™ (Dr Hatem Elshobaki), and â€˜Diabetic nephropathyâ€™ (Dr Mohamed Amin). Information booths are to be set up at all hospitals,

Primary Care Screening for Dementia and Mild Cognitive Impairment  -  Mar 11, 2008
Journal of American Medical Association (subscription),...nephropathy, and cerebrovascular disease) would not reverse with treatment. This would be considered unacceptable clinical practice for diabetes.

Unusual 11 Mid-Day Movers 3/10: TCM, NFS, IOM Higher; KERX, TMA ...  -  Mar 10, 2008
StreetInsider.com (subscription),...(Nasdaq: KERX) 86.9% LOWER; announced top-line results from its SUN-MICRO Phase 3 clinical trial of Sulonex for the treatment of diabetic nephropathy.

Search the web for more resources on

Web health.mongabay.com

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.